Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Curriculum Vitae 1. Sept. 30, 2014. I. PERSONAL 2. Name : Subbarayan R Pochi 3. Office Phone number : 305-243-4887 4. Current Academic Rank : Research Assistant Professor 5. Current Track of Appointment : Research track 6. Primary Department : Medicine 7. Secondary or Joint Departmental Appointments : Nil 8. Division : Hematology & Oncology 9. Citizenship : USA & Overseas Citizen of India (OCI) 10. Visa Type : Citizen II. HIGHER EDUCATION 11. Institutional : M.Sc. University of Madras, June 1988. Ph.D., Banaras Hindu University, April 1994. 12. Non-Institutional : Nil 13. Certification, Licensure : CITI certification - Current. “Translational Research Boot camp’ conducted by the CTSI” Sept. 10-14, 2012. III. EXPERIENCE 14. Academic: University of Miami Miller School of Medicine; Research Assistant Professor, Excelsior College Online Adjunct Faculty Kaplan University Online Adjunct Faculty Miami Dade College, Miami, FL Adjunct Faculty University of Miami Miller School of Medicine Assistant Scientist University of Miami Miller School of Medicine Postdoctoral Research Associate National Institute of Genetics, Mishima, Japan Researcher National Institute of Health, Tokyo, Japan STA Fellow Center for Cellular & Molecular Biology, India Postdoctoral Fellow 15. Hospital : Nil 16. Non-Academic : Nil 17. Military : Nil Since Oct. 2007 2008 - 2012 2007 - 2008 2005 – 2008 2002 – 2007 1999 2002 1997 – 1998 1995 – 1996 1994 – 1995 1 IV. PUBLICATIONS: 18. Books and monographs published 1. Subbarayan PR*, Braunschweiger P and Ardalan B, Inhibition of RNA synthesis by 5fluorouridine accounts for its cyto toxicity on colorectal cancer cells in vitro In: New Messenger RNA Research Communications, Kwang LB Ed., Nova Science Publishers, Inc. 99-111, 2007. 19. Referred Journal articles (*Corresponding author) 2. Subbarayan PR*, Ardalan B. In the war against solid tumors arsenic trioxide need partners, J Gastrointest Canc, 45(3):363-371, 2014 (10.1007/s12029-014-9617-8). 3. Subbarayan PR*, Sarkar M, Nathanson L, Doshi N, Lokeshwar B, Ardalan B. In vitro global gene expression analyses support the ethno-pharmacological use of Achyranthes aspera, Evid Based Complementary Altern Med. Volume 2013, Article ID 471739, 13 pages, 2013 http://dx.doi.org/10.1155/2013/471739. 4. Subbarayan PR*, Sarkar M, NagarajaRao S, Philip S, Kumar P, Altman N, Reis I, Ahmed M, Ardalan B, Lokeshwar B. Achyranthes aspera (Apamarg) Leaf extract inhibits human pancreatic tumor growth in athymic mice by apoptosis, J. Ethnopharmacology, 142: 523-530, 2012. 5. Hammad H, Sarkar M, Subbarayan PR*, Ardalan B, Thymidylate synthase 5’ UTR polymorphic allele distribution in South Florida population. Journal of Cancer Therapy, 3:173176, 2012. 6. Hammad H, Sarkar M, Gupta N, Ardalan B, Subbarayan PR*. The presence of three repeats in the 5' UTR region of thymidylate synthase (TS) is associated with increased TS mRNA expression in cultured human cancer cell lines in vitro. Oncology Reports, 27(1):246-249, 2012. 7. Paley EL, Paley DE, Merkulova-Rainon T, Subbarayan PR. Hypoxia signature of splice forms of tryptophanyl-tRNA synthetase marks pancreatic cancer cells with distinct metastatic abilities. Pancreas. 40(7):1043-56, 2011. 8. Podolsky L, Oh M, Subbarayan PR, Francheschi D, Livingstone A, Ardalan B. 5-Fluorouracil/ Leucovorin and Arsenic Trioxide for Patients with Refractory/Relapsed Colorectal Carcinoma: A Clinical Experience. Acta Oncologica, 50: 602-605, 2011. 9. Subbarayan PR*, Sarkar M, Impellizzeri S, Raymo F, Lokeshwar BL, Kumar P, Agarwal R and Ardalan B. Anti proliferative and anti cancer properties of Achyranthes aspera: Specific inhibitory activity against pancreatic cancer cells and the expression of metastatic and angiogenic promoting genes in vitro. J. Ethnopharmacology, 131: 78–82, 2010. 10. Subbarayan PR*, Sarkar M, G. Nelson G, Benitez E and Ardalan B, Chronic exposure of colorectal cancer cells to fluoropyrimidine analogues in vitro induces thymidylate synthase and suppresses p53. A molecular explanation for the mechanism of 5-FU resistance. Anticancer Res. 30(4): 1149-1156, 2010. 11. Subbarayan PR*, Lee K and Ardalan B, Arsenic trioxide suppresses thymidylate synthase in 5FU resistant colorectal cancer cell line HT29 (HT29FU) in vitro sensitizing them back to 5-FU. Anticancer Res. 30(4): 1157-1162, 2010. 2 12. Ardalan B, Subbarayan PR, Ramos Y, Gonzalez M, Fernandez A, Mezentsev D, Reis I, Duncan R, Podolsky L, Lee K, Lima M, Ganjei-Azar P, A Phase I Study of 5-FU (plus Leucovorin) and Arsenic Trioxide for Patients with Refractory/Relapsed Metastatic Colorectal Carcinoma, Clin Cancer Res; 16(11); 3019–27, 2010. 13. Gennaro ED, Bruzzese F, Pepe S, Leone A, Delrio P, Subbarayan PR, Avallone A and Budillon A. Modulation of thymidylate synthase and p53 expression by HDAC inhibitor vorinostat resulted in synergistic antitumor effect in combination with 5FU or Raltitrexed. Cancer Biology & Therapy 8(9):782-91, 2009. 14. Subbarayan PR*, Wang PG, Lampidis TJ, Ardalan B, and Braunschweiger P, Differential expression of Glut1 mRNA and protein levels correlates with increased sensitivity to the glycoconjugated nitric oxide donor (2-glu-SNAP) in different tumor cell types. J. Chemotherapy 20(1): 106-111, 2008. 15. Paley EL, Smelyanski L, Malinovskii V, Subbarayan PR, Berdichevsky Y, Posternak N, Gershoni JM, Sokolova O, Denisova G, Mapping and molecular characterization of novel monoclonal antibodies to conformational epitopes on NH2 and COOH termini of mammalian Tryptophanyl-tRNA Synthetase reveal link of the epitopes to aggregation and Alzheimer's disease. Mol Immunol. 44(4):541-557, 2007. 16. Subbarayan PR*, Lima M and Ardalan B, Arsenic trioxide/ascorbic acid therapy in patients with refractory metastatic colorectal carcinoma: A clinical experience, Acta Oncologica 46(4):557-61, 2007. 17. Subbarayan PR* & Sarkar M, A stop codon dependent internal Secondary Translation Initiation Region in Escherichia coli. RNA 10(9):1359-1365, 2004. 18. Subbarayan PR* & Sarkar M, Escherichia coli rpoS gene has an internal Secondary Translation Initiation Region. Biochem.Biophys.Res.Commun 313(2): 294-299, 2004. 19. Subbarayan PR* & Sarkar M, A comparative study of variation in codon 33 of the rpoS gene in Escherichia coli K12 stocks: implications for the synthesis of sigma(s). Mol Genet Genomics. 270(6): 533-538, 2004. 20. Gowrishankar J, Yamamoto K, Subbarayan PR & Ishihama A, Mutants of RpoS (s) of Escherichia coli deleted for N-terminal subregion 1.1 or C-terminal region 4: in vitro properties. J. Bacteriol. 185(8): 2673-2679, 2003. 21. Subbarayan PR*, Sarkar M & Ardalan B, Isolation of Genomic DNA from Human Whole Blood, Biotechniques 33(6): 1231-1234, 2002. 22. Subbarayan PR & Deutscher MP, Escherichia coli RNase M is a multiply altered form of RNase I, RNA 7: 1701-1707, 2001. 23. Subbarayan PR, Shichishima T, Yoshida H, Maruyama S & Naiki M, Report of one patient with paroxysmal cold hemoglobinuria, Int. J. Hematol. 65: 165-167, 1997. 24. Subbarayan PR, Sarkar M & Vinayak M, Analysis of transfer RNA during the early embryogenesis of the freshwater teleost, Heteropneustes fossilis, Mol. Biol. Rep. 21(2): 113-118, 1995. 25. Subbarayan PR & Vinayak M, Improvement in the quality of milt of Heteropneustes fossilis, J Sci. Ind. Res. 44: 23-26, 1995. 3 26. Sarkar M, Subbarayan PR & Vinayak M, Transfer RNA analysis during the reproductive cycle of a freshwater teleost, Heteropneustes fossilis, Mol. Biol. Rep. 20(1): 9-14, 1994. 20. Other works, Publications and abstracts: Conference Proceedings 27. Sarkar M, Subbarayan PR, Philip S, Kumar P, Ahmed M, Ardalan B, Lokeshwar B (2012). Systematic analyses validates in vitro and in vivo anticancer properties of the Ayurvedic plant Achyranthes aspera, Planta Medica 78(11): 1182 (PI167). 28. Subbarayan PR, Sarkar M, Philip S, Kumar P, Ahmed M, Ardalan B, Lokeshwar B (2012). From Bedside to Bench: Characterization of in vitro and in vivo anticancer properties of Achyranthes aspera (Apamarg) Leaf extract. Biomedical Papers 156(1): S21 O-30. 29. Jin X, Zimmers TA, Subbarayan PR, Zhanga Z, Ardalan A and G. Koniaris LG (2008), QS61. IL-6 Is An Essential Inhibitor of Apoptosis Following Intestinal Injury. J. Surg. Res. 144 (2): 293. 30. L. Paley, V. Malinovskii, S.R. Pochi, B. Ardalan and T.J. Lampidis (2004), Hypoxia inducible transcriptional factor-1a is associated with mitosis under normoxia and hypoxia. The Miami Nature Biotechnology winter symposia, Miami, Fl, USA. (http://www.med.miami.edu/mnbws/Malinovskii-.pdf). 31. Subbarayan PR*, M. Sarkar, G. Nelson, E. Benitez and B. Ardalan (2004), Cyclin B1 mediated G2/M DNA damage checkpoint is affected in 5FU resistant colorectal cancer HT29 cells. The Miami Nature Biotechnology winter symposia, Miami, Fl, USA. (http://www.med.miami.edu/mnbws/Pochi-.pdf). Abstracts 32. Subbarayan PR*, Sarkar M, Nathanson L, Doshi N, Lokeshwar B, Ardalan B. In vitro global gene expression analyses support the medicinal use of Achyranthes aspera. Evaluating Bioactive Food Components in Obesity and Cancer Prevention, September 27-29, 2013, Fort Walton Beach, FL, USA. 33. Subbarayan PR, Sarkar M, Lokeshwar B, Ardalan B. Systematic investigations of the anti cancer properties of the medicinal plant Achyranthes aspera. GRC Conference, “Natural Products.” July 28 – Augurst 2, 2013, Andover NH, USA. 34. Subbarayan PR, Sarkar M, NagarajaRao S, Pilip S, Kumar P, Ahmed M, Ardalan B, Lokeshwar B. Achyranthes aspera (Apamarg) Leaf extract is preferentially cytotoxic to pancreatic cancer cells in vitro and inhibits human pancreatic tumor growth in athymic mice by apoptosis; 13th Annual Zubrod Memorial Lecture and Sylvester Cancer Research Poster Session; May 18, 2012, Miami, FL, USA. 35. Kumar P, Subbarayan PR, Sarkar M, NagarajaRao S, Pilip S, Altman N, Ahmed M, Ardalan B, Lokeshwar B. Anticancer Activity of Achyranthes aspera (Apamarg); International Conference on Cancer Prevention, Diagnosis & Treatment, January 21-22, 2012, Jaipur, INDIA. 36. Subbarayan PR, Ramos Y, Fernandez A, Gonzalez M, Mezentsev D, Bongato T, Ganjei-Azar P, Reis I, Lee K, Ardalan B (2009), Phase I study of escalating doses of 5-FU and Arsenic Trioxide (As2O3) in patients with refractory metastatic colorectal carcinoma, American Association for Cancer Research 100th Annual Meeting, April 18-22, 2009, Denver, CO, USA. 4 37. Hammad H, Subbarayan PR and Ardalan B (2008), 5’ and 3’ polymorphic region of the TS gene as a prognostic marker in 5FU based chemotherapy, American Association for Cancer Research 99th Annual Meeting, April 12-16, 2008, San Diego, CA, USA. 38. S. R. Pochi, R. Yipsel, D. Mezentsev, P. Ganjei-Azar, I. Reis, K. Lee, B. Ardalan (2008), A continued report on phase I study of escalating doses of 5-FU and arsenic trioxide (As2O3) in patients with refractory metastatic colorectal carcinoma, 2008 Gastrointestinal Cancers Symposium, ASCO-GI, Jan. 2008, Orlando, FL, USA. 39. Subbarayan PR, Sarkar M, Nelson G, Benitez E and Ardalan B (2007), Chronic exposure of CRC cell line HT29 to 5-FU or FUR alters multiple independent pathways, American Association for Cancer Research 98th Annual Meeting, April 14-18, 2007, Los Angeles, CA, USA. 40. Subbarayan PR, Ramos Y, Mezentsev D, Bongato T, Ganjei-Azar P, Reis I, Kozyreva O, Lee K, Ardalan B (2007), A Phase I study of 5-FU and arsenic trioxide for patients with refractory metastatic colorectal carcinoma, 2007 Gastrointestinal Cancers Symposium, ASCO-GI, Jan.1921, 2007, Orlando, FL, USA. 41. Subbarayan PR, Lee P and Ardalan B (2005), Inhibition of RNA synthesis by 5-fluorouridine accounts for its cyto toxicity on colorectal cancer cells in vitro, American Association for Cancer Research 96th Annual Meeting, April 16-20, 2005, Anaheim, CA, USA. 42. Subbarayan PR, Wang PG, Lampidis TJ, Ardalan B and Braunschweiger P (2005). Increased expression of Glut1 mRNA and protein levels correlates with increased sensitivity to glycolconjugated nitric oxide donors in different cell types, American Association for Cancer Research 96th Annual Meeting, April 16-20, 2005, Anaheim, CA, USA. 43. Subbarayan PR, Sarkar M, Nelson G, Shabashvili D & Ardalan B (2004), Akt1/PKB pathway is affected in 5-FU resistant HT-29 cells. American Association for Cancer Research 95th Annual Meeting, March 27-31, 2004, Orlando, Fl, USA. 44. Maher JC, Priebe S, Savaraj N, Paley E, Liu H, Subbarayan PR & Lampidis TJ (2004), Differential sensitivity to 2-deoxy-D-glucose between two pancreatic cell lines correlates with GLUT 1 expression. American Association for Cancer Research 95th Annual Meeting, March 27-31, 2004, Orlando, Fl, USA. 45. Subbarayan PR, Sarkar M, & Vinayak M (1994), The initiation of RNA and protein synthesis in Heteropneustes fossilis, Ann. Meetings of the American Association for the Advancement of Science, Feb. 18-23, 1994, San Francisco, USA. 46. Subbarayan PR, Sarkar M & Vinayak M (1994), Onset of embryonic transcription in the freshwater teleost, Heteropneustes fossilis, XVI IUBMB, Sept. 19-22, 1994, New Delhi, India. 47. Vinayak M, Sarkar M & Subbarayan PR (1994), Accumulation of tRNA in ovary during reproductive cycle of a freshwater teleost, Heteropneustes fossilis, XVI IUBMB, Sept. 19-22, 1994, New Delhi, India. 48. Abdulla A, Subbarayan PR & Ardalan A (2002), Standardization of a strategy to analyse tandem repeats in the 5'UTR of hTS gene, University of Miami, Department of Biology Undergraduate Research Seminar, Coral Cables, Fl, USA. 5 49. Subbarayan PR, Sarkar M & Vinayak M (1993), Studies of RNA & protein synthesis during embryonic development of Heteropneustes fossilis, 62nd Ann. Gen. Body Meetings of the Society of Biological Chemists (India), Dec. 19-22, 1993, Madurai, India. 50. Sarkar M, Subbarayan PR & Vinayak M (1993), Analysis of tRNA during ovarian cycle of Heteropneustes fossilis, XVI All India Cell Biology Conference and Symposium, Jan. 1-3, 1993, Varanasi, India. 51. Subbarayan PR, Sarkar M & Vinayak M (1992), tRNA studies in preparatory phase of a freshwater teleost, Heteropneustes fossilis, 61st Ann. Gen. Body Meeting of the Society of Biological Chemists (India), Dec. 21-23, 1992, Hyderabad, India. 52. Sarkar M, Subbarayan PR & Vinayak M (1992), Quantitative and qualitative analysis of tRNA from ovary, male & female liver during preparatory phase of a teleost, 6th National Conference of AGI, Nov. 17-19, 1992, Aligarh, India. 21. Other works accepted for publication: 53. Block K, …, Subbarayan PR et. al. A Broad-Spectrum Integrative Design for Cancer Therapy, Seminars in Cancer Biology. 2014. 54. Jiang WG, Sanders AJ, Katoh M, Ungefroren H, Gieseler F, Prince M, Thompson S, Zollo Mf, Spano D, Dhawan P, Sliva D, Subbarayan RP, Sarkar M, Honoki K, Fujii H, Georgakilas A, Amedei A, Niccolao E, Amin A, Ashraf SS, Ye La, Helferich B, Yang X, Boosani CS, Guha G, Ciriolo MR, Aquilano K, Chen S, Azmi AS, Keith WN, Bilsland A, Bhakta D, Halicka D, Nowsheen S, Pantano F, Santini D. Tissue Invasion and Metastasis: Molecular, Biological and Clinical Perspectives, Seminars in Cancer Biology. 2014. 55. Subbarayan PR. Impact and challenges of Chemoinformatics in drug discovery. In: Artificial Neural Network for Drug Design, Delivery and Disposition. Ed. Pathak Y. Puri M, Sutariya VK, Tipparaju S and Moreno W. (2015). 56. Subbarayan PR*, Doshi N, Wang Z, Robbins D, Capobianco T, Ardalan. B Computational motif analyses confirm the presence of Gli consensus sequence in thymidylate synthase transcriptional regulatory region (Communicated). V. PROFESSIONAL 22. Funded Research Performed: Pre-doctoral Fellowship: Junior Research Fellow, University Grants Commission, India – 1988 - 1992 Senior Research Fellow, University Grants Commission, India – 1992 - 1994 Role: STA Fellow Effort: 100% Mentor: Dr. Masaharu Naiki, National Institute of Health, Tokyo, Japan. STA Postdoctoral Fellowship, Science & Technology Agency, Japan Title: Cloning and characterization of fimbrial antigen in ETEC K99 1995-1996 6 CREST Role: Researcher Effort: 100% 1997-1998 Title: Determination of the Hierarchy of Gene Expression. Project of the Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Japan, PI: Dr. Akira Ishihama, National Institute of Genetics, Mishima, Japan Project Objective: To elucidate the stationary phase phenomenon in Escherichia coli and to unravel the mechanism of stationary phase regulation by rpoS gene. Sylvester SCCC 2003073 Role: Investigator Effort: 100% 2004 - 2006 PI: Dr. Bach Ardalan MD Title: Basic Science Research Model for Gastrointestinal Cancers 5FU or FUdR is used as a standard chemotherapy agent to treat colorectal cancer patients. However, the efficacy has been linked to thymidylate synthase expression. In this study we collect blood and tissue samples from the patients undergoing treatment and monitor the TS profile. My role in this project is investigator. NIH R21 1R21CA117116-01A2 Role: Investigator Effort: 100% June 2007 to May 2009 PI: Dr. Bach Ardalan MD Title: Reversal of 5-FU resistance by arsenic trioxide in colorectal carcinoma It is a Phase I clinical trial. The enrolled patients receive a combination of arsenic trioxide and 5FU/Leucovorin. As a co-PI, I help to investigate the role of arsenic trioxide in regulating thymidylate synthase (TS) gene expression in the peripheral blood and tumor tissues of the study participants. As a collaborator my role in this project is to manage the basic research aspects of this Phase I clinical trial. NIH R25: 5R25GM050083-06 Role: Collaborator Sept. 1996 to March 2008 Role: Mentor for UM-MDC bridge scholars. Under this program I have trained about 10 minority scholars. PI: Dr. Michael Gaines Title: Miami-Dade College - University of Miami Bridge Program It is an innovative program to motivate, recruit and retain freshman scholars to do biology research and to attract students to Ph.D. programs and research careers. Essentially these students are matched with UM researcher to work in their laboratories. NIH 5R25GM076419-02 March 2006 to March 2010 Role: Mentor for IMSD scholars PI: Dr. Michael Gaines Project Title: Initiative for Minority Student Development / Increasing Minority Student Diversity (IMSD). The goal is to support underrepresented minorities in graduate programs in the biomedical sciences through fellowships. 7 American Cancer Society (ACS), Institutional Research Grant (2010) Nov. 2010 – October 2011 Role: PI Project Title: Identification of anticancer agent(s) from the plant Achyranthes aspera The goal of this project is 1. to investigate the in vivo anti tumor activity of methanol extract of the leaves of A. aspera, 2. chemical identification and purification of the active antic cancer agent in this preparation. IDRI Grant #102504 08/01/11 – 05/31/13 Role: PI Project Title: Identification of Anticancer Molecule form the Medicinal Herb Achyranthes aspera The goal of this project is to identification and characterization of the active molecule in LE, elucidate the in vivo biological activity of the purified compound. CTSI Pilot Research Grant (CTSI-2013-P03) 01/02/2013 - 05/31/2014 Role: PI Project Title: Characterization of bioactive saponins with anticancer activity from Achyranthes aspera The goal of this project is to characterize the bioactive saponins in A. aspera. NHMFL user project ML-Pochi-001 03/01/2013 – 02/29/2016 Role: PI Project Title: Structural determination of the active anti cancer molecule in Achyranthes aspera The goal of this project is to use multi dimensional NMR at Advanced Magnetic Resonance Imaging and Spectroscopy Facility, National High Magnetic Field Laboratory (NHMFL) to resolve the structure of the active anticancer molecule in A. aspera. Grant Editing Support Award 08/01/2014 - 07/31/2015 Role: PI Project Title: Preclinical Studies of the Cytotoxicity of Nayurvin, A Plant-derived Porphyrin The award enables me consult paid external experts critique my grant application. SEEDS You Choose Awards (PI: Sarkar M, Ph.D.) 01/12/2013 – 05/31/2014 Role: Collaborator Project Title: "Investigation of Developmental Toxicity of a Newly Discovered Anticancer Molecule 'Nayurvin' in Zebrafish (Danio rerio)" The goal of the project is to use Zebrafish model to test the toxicity of Nayurvin. This investigation will also prepare the basis for future undergraduate research President’s Faculty Research and Development Grant 05/01/2014 – 04/30/2015 Role: Collaborator (PI: Nathanson L, Ph.D.) Project Title: Explorative gene expression and pathway analysis for innovative cancer treatment The goal of this project is to generate preliminary data for a large cohort study Pending Grants: NIH R-01 Role: PI April 2015- March 2020 Title: Preclinical studies of the cytotoxicity of Nayurvin, a plant-derived porphyrin Bank Head Coley Research Grant Role: PI Feb. 2015- Jan. 2018 Title: Preclinical studies of the cytotoxicity of Nayurvin, a plant-derived porphyrin 8 SEEDS You Choose Leadership Award Role: PI Workshop on Clear and Concise Writing Skills for Academic Settings 2014- March 2015 23. Editorial responsibilities Chair, Editorial Board for the Newsletter of the American Association of Indian Scientists in Cancer Research (AAISCR) - 2007-2010. Peer Reviewer for: Cancer, Current Pharmaceutical Design, Cancer and Anticancer Drugs, J of Biomedicine and Biotechnology, Evidence-Based Complementary and Alternative Medicine, Journal of Biomedicine and Biotechnology, Journal of Pharmacognosy and Phytotherapy, African Journal of Agricultural Research, Molecular Biology Report, European Journal of Medicinal Plants, Cancer, etc. 24. Professional and Honorary Organizations (member, officer, date) Active member Life Member Life Member Life Member American Association for Cancer Research (USA), since 2002 American Association of Indian Scientists in Cancer Research (AAISCR) Society of Biological Chemists (India) Indian Association of Cancer Research (India) 25. Honors and awards: (Selected few) Listed in Who’s is Who in Medicine and Healthcare, 5th Edition 2004 STA Fellow, Science & Technology Agency, Japan 1995 ‘YOUNG SCIENTIST’ Award, International Union of Biochemistry and Molecular Biology 1994 26. Postdoctoral Fellowships: University of Miami Miller School of Medicine Postdoctoral Research Associate National Institute of Health, Tokyo, Japan STA Fellow Center for Cellular & Molecular Biology, India Postdoctoral Fellow 1999 - 2002 1995 – 1996 1994 – 1995 27. Other Professional Activities: Reviewer of Grants: In August 2014, I was selected as a reviewer under Early Career Reviewer (ECR) program at the Center for Scientific Review, NIH. Resource person: Real Time PCR dry workshop Part of IACR conference and Symposium, Ahmadabad, Gujarat, India Feb. 2008 Conference Session Chair: “Natural Anticancer Drugs” (NAD), Olomouc, Czech Republic. Indian Association for Cancer Research Conference and Symposium Ahmadabad, Gujarat, India. July 2, 2012. Feb, 2008 9 Invited lectures: “Natural Anticancer Drugs” (NAD), Olomouc, Czech Republic. Indian Association for Cancer Research Conference and Symposium Ahmadabad, Gujarat, India. Banaras Hindu University, India Center for Cellular and Molecular Biology Indian Institute of Technology, Kharagpur, Roorky, Chennai, India Rajiv Gandhi Center for Biotechnology, Trivandrum, India July 2, 2012. Feb, 2008 May 2004 June 2004 May, June 2004 June 2004 Chair - Editorial Board: Quarterly Newsletter of the American Association of Indian Scientist in Cancer Research (AAISCR) 2007-2010 VI. TEACHING 28. Teaching Awards received : Nil 29. Teaching specialization : I teach basic biology courses that covers various aspects of life sciences viz introductory biology, genetics, developmental biology etc. I have been certified to teach BS degree program of the Miami Dade College (2005). I am trained to teach online courses for Kaplan University online and Excelsior (online) college, NY. 30. Thesis and Dissertation Advising/Postdoctoral student supervision Undergraduate research: Since 2002, I have mentored more than 19 undergraduates complete their research thesis. Research work conducted by Ms. Lisa Ramsey, 2004 and Ms. Hiba Hammad, 2007 were adjudged the best by a panel of independent judges. 1. Ms. Alia Abdulla 2. Mr. Dmitry Castillo 3. Ms. Lisa Ramsay 4. Mr. Philip Lee 5. Mr. Daniel Shabashvili 6. Mr. Nelson Hernandez 7. Mr. Grodonoff Nelson 8. Mr. Edilberto Benitez 9. Mr. Raveesh Richard 10. Ms. Yipsel Ramos 11. Ms. Hiba Hammad 12. Ms. Kareena Coronado 13. Mr. Michael Gonzalez 14. Mr. Anthony Fernandez 2002 2003 2004 2005 2005 2005 2006 2004 2005 2007 2007 2007 2008 2008 15. Eli Nehme 16. Nikhil Gupta 17. Shibani Singal 18. Nikesh Doshi 19. Ms. Nitya Ramalingam 2009 2011 2012 2013 Current Research Interns 20. Dr. Upama Giri, MBBS Current High School Students 21. Samantha Agron 22. Stephanie Balepogi 23. Zoe Zhang 2010 2010 2013 VII. SERVICE 31. University Committee and Administrative Responsibilities: Early Career Reviewer (ECR) program, Center for Scientific Review (CSR National Institutes of Health Member Protocol Review Committee 2014 Since 2006 10 32. Community Activities: Volunteer School safety – Pinecrest Elementary School, Pinecrest, FL Volunteer – MDC Medical Center Health Fair Feb. 18, 2006. Volunteer – Miami Book Fair International Judge – Miami-Dade County Science Fair 2003-2004 Feb. 2006 Nov. 2006 Jan. 2008 Mentor Mentor in a special program for high school students entitled, “The Conquest of Cancer and the Next Generation,” American Association for Cancer Research 97th AACR Annual Meeting, April 3, 2006, Washington DC. 98th AACR Annual Meeting, April 14-18, 2007, Los Angeles, CA. Panel Member: Associate Member Council, Grant writing workshop, AACR Annual meetings, San Francisco. April 2002 Member Asian American Advisory Board (AAAB), Miami-Dade County Since 2014 AAAB is one of the boards in the Miami-Dade County’s Office of Community Advocacy (OCA). The AAAB serves in an advisory capacity to the County Commission, the County administration, and all agencies and persons in Miami-Dade County. Founder & President (2009 – 2014) Dade BalVihar – a Sunday school to mentor children of Hindu origin Member (Since 2005) and past President (2011) Ekal Vidyalaya Foundation USA, South Florida Chapter. Under my leadership we raised record $160,000 in 2011 (http://www.deshvidesh.com/Current_Issue/Desh-Videsh-January-2012/ekal-vidyalayaflorida.html). “The Ekal Vidyalaya Foundation is a tax exempt, registered non-profit service organization dedicated to education and village development in rural India. Ekal's philosophy is to take a holistic approach to social and economic development. The Ekal movement is the largest, grassroots, non-government education movement in India, operating in over 54,081 villages and educating over 1,472,991 children in rural India” - http://www.ekal.org. *** 11